Bioreactors are vessels that are used to manufacture biologics and biosimilars such as peptides, antibodies, vaccines, and pharmaceuticals (using plant or animal cells). Fermenters are used to manufacture acids and alcohols through the fermentation of microbes. Single-use bioreactors and fermenters have witnessed a considerable surge in popularity as they meet the demands of the biopharmaceutical industry and offer higher efficiency and greater flexibility at lower costs. For instance, single-use bioreactors and fermenters are pre-sterilized and can be disposed of after use, which minimizes the chances of cross-contamination.

Serum-free media is medium type that enables cell culture to be carried out under a controlled set of conditions. There is no requirement of supplementation of serum in the serum-free media as it does not comprise any sort of animal/human serum/plasma as primary components. Some common forms of commercialized serum-free media are xeno-free media, common serum-free media, and chemically-defined media formulations for cell therapy. Companies like STEMCELL Technologies, Lonza Group AG, and Thermo Fisher Scientific Inc. manufacture small molecules as media supplements and they are generally easily available, chemically defined, and tunable.

There is significant growth in the global micropropagation market due to continuous R&D investments in technological innovation and advanced techniques to increase crop efficiency and quality in agriculture. Micropropagation is used to produce crops that are difficult to propagate using conventional methods, such as seeding or cutting. Moreover, micropropagation helps to create many progeny plants using modern plant tissue culture methods.

Novel time-lapse microscopy technologies enable the image analysis of living cells, fresh tissues, or live-in vivo models in a time-resolved manner. The imaging of live cells is done to monitor internal cellular structures, processes, and interactions to determine drug efficacy, safety, and actions reliably. It helps determine whether drugs bind to the intended target or have any off-target effects.

Biologics or biological drugs are obtained from living organisms, such as humans, animals, and microorganisms, using complex manufacturing processes and are administered closely under monitored conditions. They contrast with traditional non-biological drugs that are synthesized in laboratories using chemical processes without the use of biological components. Cancer, infectious diseases, and autoimmune diseases are those diseases that the bio pharmacy is used to prevent, treat, or cure. Biologics bring hope for treatments for diseases such as cancer, heart disease, Alzheimer's, diabetes, and rheumatoid arthritis. Biopharmaceuticals have a few side effects and promise targeted treatments with provisional measures for personalized medicine, but this area is still in its infancy.

Over the last few years, environmental regulations, and the importance of developing sustainable products have generated a tremendous demand for biobased lubricants or biodegradable lubricants. In the lubricant industry, bio-based lubricants are used as lubricating oils to reduce energy consumption and prolong the life of equipment/machinery. Several OEM equipment manufacturers and vendors in the mining marine, construction, and wind power industries are seeking environment-friendly products. Therefore, such environmental considerations and changes in consumer behavior have compelled lubricant manufacturers to formulate lubricants with lower environmental impact.

Understanding the structure and function of proteins is a major part of modern biotechnology. Determining 3D structures at atomic resolution assists in the elucidation of protein function, molecular docking, and structure-based drug design. Protein function relies on its structure and its interactions with other proteins. Therefore, protein structure analysis yields valuable information that can be used to infer protein function. The rising adoption of protein therapeutics coupled with continuous technological advancements in instruments and consumables related to NMR spectroscopy, X-Ray crystallography, cryo-electron microscopy, and small-angle X-Ray scattering is making headway in the growth of the global 3D protein structure analysis market.

The bioprinting technique involves the periodic arrangement of various biological materials, such as biochemicals and biocells, to fabricate tissues and organs. Several bioprinting techniques are used to generate 3D functional human constructs that mimic native tissues/organs. Different biomaterials based on carbohydrates, proteins, nucleic acids, and nanocomposites are used in bioprinting methods to create biocompatible and biodegradable scaffolds. These scaffolds promote cell adhesion and proliferation in the tissues engineered using 3D bioprinting techniques. Bioprinting methods have enabled researchers and manufacturers to mimic the natural tissue microenvironment to create advanced tissue models. Also, these methods have had an immense impact on the field of medicine and healthcare.